News

Singularity Hub1mon
Parkinson’s Patients Say Their Symptoms Eased After Receiving Millions of New Brain Cells
In a second study, scientists created an iPSC cell line from a donor’s skin cells and coaxed them into fresh dopamine neurons. Transplanted into seven Parkinson’s patients, the cells were shown to be ...
abc271mon
XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials
These milestones position XellSmart as a global leader in advancing innovative iPSC-derived regenerative cell therapies for CNS diseases, including Parkinson's disease and ALS. Dr. Michael Lee ...
A Pioneering Biotech Company Redefining Cell Therapy and Drug Discovery Platforms
Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...
manilatimes1mon
XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials
These milestones position XellSmart as a global leader in advancing innovative iPSC-derived regenerative cell therapies for CNS diseases, including Parkinson's disease and ALS. "April 11th marks World ...
Taiwan News1mon
XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials
These milestones position XellSmart as a global leader in advancing innovative iPSC-derived regenerative cell therapies for CNS diseases, including Parkinson's disease and ALS. Dr. Michael Lee (Xiang ...